Skip to main content
. 2009 Sep 29;106(41):17481–17486. doi: 10.1073/pnas.0903313106

Fig. 5.

Fig. 5.

Proposed mechanism of increased immunogenicity of ZPS-conjugates. ZPS-conjugates are targeted to TLR2 positive DCs and activate them through receptor engagement. Increased DC activation leads to improved priming of naive T cells specific for the conjugated protein. Enhanced T-cell help to B cells will lead to higher Ab titers and thus improved protection against infection by GBS.